Growing in areas that matter, cannabis medication producer Althea Group (ASX: AGH) has been increasing its global distribution offerings with the launch of its latest products; the Althea CBD25 soft gel capsules and the THC25 dried flower. Product development is the cornerstone of market share leadership in an industry still in its infancy. With the
Read More
The burgeoning arms of cannabis treatment have made their way to Ireland, with regulators easing restrictions which has increased the amount of qualified retailers. Currently, there is a limited number of cannabis retailers in the Republic of Ireland. Today, Althea Group Holdings (ASX: AGH) has been granted a rare opportunity to enter the Irish cannabis
Read More
The ever progressive Canadians just know how to have fun which is just one reason cannabis-infused beverages are proving a major hit in the Great White North. Seeking to capitalising on this trend is medicines and recreational cannabis company Althea (ASX: AGH) which has partnered with beer giant The Boston Beer Company (NYSE: SAM) to
Read More
If Australians have reservations about the use of medicinal cannabis to cure their ailments, there will soon be a low-cost option to trial cannabis products, with Althea Group (ASX: AGH) to launch a new range of low dosage oils to give first-time users an affordable entry point. The new ‘flexi’ cannabis oil products, as the
Read More
Global pharmaceutics and cannabis healthcare company Althea Group (ASX: AGH) has harnessed the power of telehealth through COVID-19, almost doubling web-based enquiries for their MyAccess Clinics in the UK where patients can seek medicinal cannabis treatment pathways. With the England being one of the harder nations hit by COVID-19, Althea accelerated telehealth offerings for its
Read More